Influence of relative hypoparathyroidism on the responsiveness to recombinant human erythropoietin in hemodialysis patients

Blood Purification

Volumn 21, Issue 3, 2003, Pages 220-224

  Hsu, Shih Ping ^a   Peng, Yu Sen ^a   Pai, Mei Fen ^a   Hung, Kuan Yu ^a,b   Tsai, Tun Jun ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anemia; Erythropoietin; Hemodialysis; Hypoparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESPONSE; FEMALE; GLOMERULONEPHRITIS; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HORMONE BLOOD LEVEL; HUMAN; HYPOPARATHYROIDISM; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DRUG RESISTANCE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATOCRIT; HUMANS; HYPOPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 0038355213     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070693     Document Type: Article

References (15)

1. Rao DS, Shih MS, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 1993;328:171-175.
2. Drüeke TB: Modulating factors in the hematopoietic response to erythropoietin. Am J Kidney Dis 1991;18:87-92.
3. Holy B, Drüeke TB: The parathyroid-bone axis in uremia: New insights into old questions. Curr Opin Nephrol Hypertens 1997;6:40-48.
4. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993;4:1205-1213.
5. Kcomt J, Sotelo C, Raja R: Influence of adynamic bone disease on responsiveness to recombinant human erythropoietin in peritoneal patients. Adv Perit Dial 2000;16:294-296.
6. Meytes D, Bogin E, Ma A, Dukes PP, Massry SG: Effect of parathyroid hormone on erythropoiesis. J Clin Invest 1981;67:1263-1269.
7. Urena P, Eckardt KU, Sarfati E, Zingraff J, Zins B, Roullet JB, Roland E, Drüeke T, Kurtz A: Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: Effect of parathyroidectomy. Nephron 1991;59:384-393.
8. Ishimura E, Nishizawa Y, Okuno S, Matsumoto N, Emoto M, Inaba M, Kawagishi T, Kim CW, Morii H: Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 1998;11:83-86.
9. Yun YS, Lee HC, Yoo NC, Song YD, Lim SK, Kim KR, Hahn JS, Huh KB: Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy. Diabetes Res Clin Pract 1999;46:223-229.
10. Kario K, Matsuo T, Nakao K: Serum erythropoietin levels in the elderly. Gerontology 1991;37:345-358.
11. Powers JS, Krantz SB, Collins JC, Meurer K, Failinger A, Buchholz T, Blank M, Spivak JL, Hochberg M, Baer A: Erythropoietin response to anemia as a function of age. J Am Geriatr Soc 1991;39:30-32.
12. Tagawa H, Umezu M, Saito T, Yamakado M, Nagano M, Urabe A, Takaku F: Regulatory mechanisms of erythropoietin levels in dialysis patients. Jpn J Nephrol 1990;32:297-303.
13. Macdougall IC: Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens 1994;3:620-625.
14. Rosenlof K, Fyhrquist F, Tenhunen R: Erythropoietin, aluminum, and anaemia in patients on haemodialysis. Lancet 1990;335:247-249.
15. Muirhead N, Hodsman AB: Occult infection and resistance of anemia to rHUEPO therapy in renal failure. Nephrol Dial Transplant 1990;5:232-234.